## Abstract Interleukin 1β (IL‐1β) is a multifunctional cytokine that upregulates the inflammatory response, and participates in carcinogenesis, malignant transformation, tumor growth, invasion and metastasis. Two potentially functional polymorphisms (T‐31C and C‐511T) in the __IL‐1__β gene promote
Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women
✍ Scribed by Hongxia Ma; Guangfu Jin; Zhibin Hu; Xiangjun Zhai; Wensen Chen; Shui Wang; Xuechen Wang; Jianwei Qin; Jun Gao; Jiyong Liu; Xinru Wang; Qingyi Wei; Hongbing Shen
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 105 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
p21^Cip1^ and p27^Kip1^ are cyclin‐dependent kinase inhibitors, which can arrest cell proliferation and serve as tumor suppressors. Reduced protein expression of p21^Cip1^ and p27^Kip1^ was frequently observed in a subset of cancers, including breast cancer. In this study, we hypothesized that genetic variants in CDKN1A (encode for p21^Cip1^) and CDKN1B (encode for p27^Kip1^) may modulate the risk of breast cancer. To test this hypothesis, we evaluated the associations of the polymorphisms of Ser31Arg and C+20T in CDKN1A and C−79T and Gly109Val in CDKN1B, as well as their combinations, with breast cancer risk in a case‐control study of 368 breast cancer cases and 467 cancer‐free controls in a Chinese population. We found that a significantly increased risk of breast cancer was associated with the variant genotypes of CDKN1B C−79T [adjusted OR = 1.43 (95% CI = 1.03−1.98) for −79TC/TT], compared with the −79CC genotype, but no associations were observed for other variant genotypes. However, the combined variant genotypes of the 4 loci were associated with a significantly increased breast cancer risk (adjusted OR = 1.49, 95% CI = 1.11−2.01 among subjects carrying 3 or more variant alleles), especially among premenopausal women (adjusted OR= 2.30, 95% CI = 1.45−3.66). Furthermore, in premenopausal women, this significant association remained unchanged, after including other individual risk factors in the multivariate logistic regression model, suggesting an independent role of CDKN1A and CDKN1B variants in breast cancer risk. Although the exact biological mechanism remains to be explored, our findings suggest possible involvement of CDKN1A and CDKN1B variants in the etiology of breast cancer. Further large and functional studies are needed to confirm our findings. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Small, noncoding RNA molecules, called microRNAs (miRNAs), are thought to function as either tumor suppressors or oncogenes. Common singlenucleotide polymorphisms (SNPs) in miRNAs may change their property through altering miRNA expression and/or maturation, and thus they may have an effect on thous
## Abstract Growing evidence suggests that the transforming growth factor β (TGF‐β) signaling pathway occupies a central position in the signaling networks that control cell growth and differentiation. TGF‐β1 and its receptor TGF‐βRII have been correlated with the development of certain forms of ca
## Abstract The Saethre‐Chotzen syndrome is an autosomal, dominantly inherited craniosynostosis caused by mutations in the basic helix‐loop‐helix transcription factor gene __TWIST1__. This syndrome has hitherto not been associated with an increased risk of cancer. However, recent studies, using a m
## Abstract Germline mutations in __CHEK2__ have been associated with a range of cancer types but little is known about disease risks conveyed by __CHEK2__ mutations outside of the context of breast and prostate cancer. To investigate whether __CHEK2__ mutations confer an increased risk of bladder